Pre-salvage ISS and Other Important Outcome Associations in CD34 Selected Allogeneic Hematopoietic Stem Cell Transplant for Multiple Myeloma

INTRODUCTION: Despite ongoing therapeutic advances multiple myeloma (MM) remains largely incurable, and outcomes in patients who develop resistance to IMiD or proteasome inhibitor therapies remain grim. Allogeneic hematopoietic cell transplant (alloHCT) is an alternate option that may offer potentia...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Bryant, AR, Hilden, P, Giralt, S, Chung, DJ, Maloy, M, Landau, H, Landgren, O, Scordo, M, Shah, G, Smith, EL, O’Reilly, RJ, Perales, M-A, Koehne, G
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7470026/
https://ncbi.nlm.nih.gov/pubmed/31493537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2019.08.023
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados